Hemanth Kumar Manikyam: The Complex Immunology Behind Platelet Destruction in ITP
Hemanth Kumar Manikyam, Vice President of Research And Development at Botanic Healthcare, Visiting Professor at Chalapathi Institute of Pharmaceutical Sciences, Lam, shared a post on LinkedIn:
“Immune thrombocytopenia (ITP): A B-cell-macrophage immune network disorder?
Insights from Mother INP 11-Layer Analysis.
Immune Thrombocytopenia (ITP) is commonly described as a low platelet disorder.
However, our Mother INP 11-Layer analysis suggests that ITP is fundamentally an immune network disease involving autoantibody production, immune tolerance failure, chronic inflammation, excessive macrophage activity, and impaired platelet regeneration.
The primary failure nodes identified include:
- B-cell hyperactivation
- Autoantibody production against platelet glycoproteins
- Regulatory T-cell dysfunction
- Splenic macrophage overactivity
- NF-κB activation
- TNF-α and IL-6 elevation
- Megakaryocyte dysfunction
KEGG pathway prioritization highlighted B-cell receptor signaling, Fcγ receptor signaling, JAK-STAT, NF-κB, PI3K-AKT, complement activation, and cytokine-mediated immune pathways as key drivers of disease progression.
Using the Mother INP Engine, several phytochemicals emerged as high-priority restoration molecules.
Curcumin demonstrated broad immune-modulating effects through NF-κB, TNF-α, and IL-6 regulation.
Withanolides from Ashwagandha showed potential to support immune homeostasis and reduce inflammatory burden.
Quercetin demonstrated activity across cytokine signaling, oxidative stress reduction, and immune regulation pathways.
EGCG exhibited interactions with JAK-STAT and inflammatory signaling networks while supporting antioxidant defense systems.
The highest-priority recovery nodes identified were:
- Immune tolerance restoration
- Reduction of autoantibody formation
- Regulation of B-cell activity
- Suppression of excessive macrophage-mediated platelet destruction
- NF-κB modulation
- Cytokine balance restoration
- Support of megakaryocyte maturation
Network propagation analysis suggests that platelet destruction is not an isolated event but a downstream consequence of a larger immune signaling imbalance involving B cells, T cells, macrophages, cytokines, and inflammatory mediators.
The most promising phytochemical restoration cluster identified through the Mother INP framework was:
Epicatechin plus Curcumin plus Withanolides plus Quercetin plus EGCG working across multiple immune and inflammatory nodes simultaneously.
Mother INP Conclusion:
ITP is not simply a platelet deficiency disorder.
It is a systems-level immune dysregulation syndrome driven by immune tolerance failure, autoantibody production, inflammatory signaling, and hematological imbalance.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 13:0810 Posts Not to Miss This Week
-
Oct 18, 2026, 12:58Pierpaolo Di Micco: DOACs vs Vitamin K Antagonists in Long-Term Anticoagulation
-
Oct 18, 2026, 12:51Arianne Missimer: Understanding Ferritin Levels Beyond the Normal Range
-
Oct 18, 2026, 12:37Roberto C. Iglesias: Colon Cancer Prevention Beyond Supplements and Vitamins
-
Oct 18, 2026, 12:27Rafael Alejandro Camero Del Vecchio: Paroxysmal Nocturnal Hemoglobinuria Advancing Complement Inhibition with Ravulizumab
-
Oct 18, 2026, 12:26Abdul Mannan: When INR Misleads – Rethinking Bleeding Risk in Cirrhosis
-
Oct 18, 2026, 12:14Stéphane Laurent: The People and Technology Behind Safe Blood Transfusion
-
Oct 18, 2026, 12:14Abhi Kapuria: When VTE Prophylaxis Breaks Down in the ICU
-
Oct 18, 2026, 11:37Lee Anne Sorto: Beyond Compliance – Making Audits Count in Transfusion Safety